NBIX
Neurocrine Biosciences Inc
NASDAQ: NBIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$150.59
-2.07% today
Updated 2026-06-05
Market cap
$16.06B
P/E ratio
24.58
P/S ratio
5.18x
EPS (TTM)
$6.50
Dividend yield
—
52W range
$122 – $170
Volume
1.2M
Neurocrine Biosciences Inc (NBIX) Insider transactions
Net insider activity
Net buying (50,242 shares)
Buy transactions
48
Sell transactions
52
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | KESWANI, SANJAY CHANDRU | Chief Medical Officer | Sale | 3,212 | — | — |
| 2026-06-02 | KESWANI, SANJAY CHANDRU | Chief Medical Officer | Buy | 3,212 | — | — |
| 2026-06-02 | KESWANI, SANJAY CHANDRU | Chief Medical Officer | Sale | 1,733 | $154.84 | $268337.72 |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Sale | 24,965 | — | — |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Buy | 24,965 | $81.49 | $2.03M |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Sale | 14,214 | $154.83 | $2.20M |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Sale | 9,521 | $157.62 | $1.50M |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Sale | 5,466 | $155.46 | $849725.78 |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Sale | 4,216 | $156.77 | $660925.46 |
| 2026-06-02 | COOKE, JULIE | Chief Human Resources Officer | Sale | 3,520 | $158.59 | $558235.74 |
| 2026-06-01 | ONYIA, JUDE | Chief Scientific Officer | Sale | 11,000 | — | — |
| 2026-06-01 | ONYIA, JUDE | Chief Scientific Officer | Buy | 11,000 | $84.74 | $932140.00 |
| 2026-05-29 | DELAET, INGRID | Chief Regulatory Officer | Sale | 2,261 | — | — |
| 2026-05-29 | DELAET, INGRID | Chief Regulatory Officer | Sale | 2,261 | $156.71 | $354321.31 |
| 2026-05-27 | SHERWIN, STEPHEN A | Director | Buy | 2,567 | — | — |
| 2026-05-27 | SHARP, SHALINI | Director | Buy | 2,567 | — | — |
| 2026-05-27 | RASTETTER, WILLIAM H | Director | Buy | 2,567 | — | — |
| 2026-05-27 | POPS, RICHARD F | Director | Buy | 2,567 | — | — |
| 2026-05-27 | POON, CHRISTINE A | Director | Buy | 2,567 | — | — |
| 2026-05-27 | ONYIA, JUDE | Chief Scientific Officer | Sale | 11,000 | — | — |
| 2026-05-27 | ONYIA, JUDE | Chief Scientific Officer | Buy | 11,000 | $84.74 | $932140.00 |
| 2026-05-27 | NORWALK, LESLIE V | Director | Buy | 1,284 | — | — |
| 2026-05-27 | NORWALK, LESLIE V | Director | Buy | 2,624 | — | — |
| 2026-05-27 | MORROW, GEORGE J | Director | Buy | 2,567 | — | — |
| 2026-05-27 | MERCIER, JOHANNA | Director | Buy | 2,567 | — | — |
| 2026-05-27 | LYONS, GARY A | Director | Buy | 1,284 | — | — |
| 2026-05-27 | LYONS, GARY A | Director | Buy | 2,624 | — | — |
| 2026-05-27 | GORMAN, KEVIN CHARLES | Director | Buy | 5,248 | — | — |
| 2026-05-26 | BOYER, DAVID W. | Chief Corp. Affairs Officer | Sale | 3,888 | $156.64 | $609023.32 |
| 2026-05-21 | SHERWIN, STEPHEN A | Director | Sale | 3,318 | — | — |
| 2026-05-21 | SHERWIN, STEPHEN A | Director | Buy | 3,318 | — | — |
| 2026-05-21 | SHARP, SHALINI | Director | Sale | 1,659 | — | — |
| 2026-05-21 | SHARP, SHALINI | Director | Buy | 1,659 | — | — |
| 2026-05-21 | RASTETTER, WILLIAM H | Director | Sale | 3,318 | — | — |
| 2026-05-21 | RASTETTER, WILLIAM H | Director | Buy | 3,318 | — | — |
| 2026-05-21 | POPS, RICHARD F | Director | Sale | 3,318 | — | — |
| 2026-05-21 | POPS, RICHARD F | Director | Buy | 3,318 | — | — |
| 2026-05-21 | POON, CHRISTINE A | Director | Sale | 3,318 | — | — |
| 2026-05-21 | POON, CHRISTINE A | Director | Buy | 3,318 | — | — |
| 2026-05-21 | NORWALK, LESLIE V | Director | Sale | 1,659 | — | — |
| 2026-05-21 | NORWALK, LESLIE V | Director | Buy | 1,659 | — | — |
| 2026-05-21 | MORROW, GEORGE J | Director | Sale | 3,318 | — | — |
| 2026-05-21 | MORROW, GEORGE J | Director | Buy | 3,318 | — | — |
| 2026-05-21 | MERCIER, JOHANNA | Director | Sale | 3,318 | — | — |
| 2026-05-21 | MERCIER, JOHANNA | Director | Buy | 3,318 | — | — |
| 2026-05-21 | LYONS, GARY A | Director | Sale | 1,659 | — | — |
| 2026-05-21 | LYONS, GARY A | Director | Buy | 1,659 | — | — |
| 2026-05-19 | GORMAN, KEVIN CHARLES | Director | Sale | 205,088 | — | — |
| 2026-05-19 | GORMAN, KEVIN CHARLES | Director | Sale | 245,088 | $154.33 | $37.82M |
| 2026-05-19 | GORMAN, KEVIN CHARLES | Director | Buy | 205,088 | $43.24 | $8.87M |
| 2026-05-15 | POPS, RICHARD F | Director | Sale | 15,000 | — | — |
| 2026-05-15 | POPS, RICHARD F | Director | Sale | 15,000 | $157.65 | $2.36M |
| 2026-05-12 | NORWALK, LESLIE V | Director | Sale | 3,810 | $155.01 | $590601.05 |
| 2026-03-04 | ABERNETHY, MATT | Chief Financial Officer | Sale | 2,249 | — | — |
| 2026-02-20 | ONYIA, JUDE | Chief Scientific Officer | Sale | 3,110 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Buy | 55,119 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Buy | 9,669 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Sale | 2,717 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Sale | 2,690 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Buy | 19,935 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Sale | 10,755 | $124.12 | $1.33M |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Buy | 2,717 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Buy | 2,690 | — | — |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Sale | 1,466 | $124.12 | $181959.92 |
| 2026-02-13 | ONYIA, JUDE | Chief Scientific Officer | Sale | 1,452 | $124.12 | $180222.24 |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Buy | 34,909 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Buy | 6,124 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Sale | 2,083 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Sale | 2,017 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Buy | 9,968 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Sale | 5,378 | $124.12 | $667517.36 |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Buy | 2,083 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Buy | 2,017 | — | — |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Sale | 1,124 | $124.12 | $139510.88 |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Sale | 1,089 | $124.12 | $135166.68 |
| 2026-02-13 | LIPPOLDT, DARIN | Chief Legal Officer | Sale | 365 | — | — |
| 2026-02-13 | KESWANI, SANJAY CHANDRU | Chief Medical Officer | Buy | 35,827 | — | — |
| 2026-02-13 | KESWANI, SANJAY CHANDRU | Chief Medical Officer | Buy | 6,285 | — | — |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Sale | 5,604 | — | — |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Sale | 5,377 | — | — |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Buy | 63,724 | — | — |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Sale | 34,380 | $124.12 | $4.27M |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Buy | 5,604 | — | — |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Buy | 5,377 | — | — |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Sale | 3,024 | $124.12 | $375338.88 |
| 2026-02-13 | GORMAN, KEVIN CHARLES | Director | Sale | 2,901 | $124.12 | $360072.12 |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Buy | 114,830 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Buy | 20,142 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Sale | 2,566 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Sale | 2,241 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Buy | 9,968 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Sale | 5,378 | $124.12 | $667517.36 |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Buy | 2,566 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Buy | 2,241 | — | — |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Sale | 1,385 | $124.12 | $171906.20 |
| 2026-02-13 | GANO, KYLE | Director, Chief Executive Officer | Sale | 1,210 | $124.12 | $150185.20 |
| 2026-02-13 | DELAET, INGRID | Chief Regulatory Officer | Buy | 31,234 | — | — |
| 2026-02-13 | DELAET, INGRID | Chief Regulatory Officer | Buy | 5,479 | — | — |
| 2026-02-13 | DELAET, INGRID | Chief Regulatory Officer | Sale | 1,401 | — | — |
| 2026-02-13 | DELAET, INGRID | Chief Regulatory Officer | Sale | 1,359 | — | — |
Frequently asked questions
Are NBIX insiders buying or selling?
Over the transactions on record, NBIX insiders have been net sellers, with about $56.41M in stock sold across 52 sales, against 4 open-market purchases.
Does insider selling at NBIX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which NBIX insiders are selling the most?
Recent selling is concentrated in a few names. GORMAN, KEVIN CHARLES accounts for the largest share on record, with about $42.83M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.